» Articles » PMID: 15794927

Megakaryocytes Modulate Osteoblast Synthesis of Type-l Collagen, Osteoprotegerin, and RANKL

Overview
Journal Bone
Date 2005 Mar 30
PMID 15794927
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously reported evidence that megakaryocytes may play a role in bone remodeling, possibly by interactions with cells at the bone surface. To investigate the direct effects of megakaryocytes on osteoblasts, maturing megakaryocytes (CD61 positive cells) were isolated and added to cultures of human osteoblasts. Osteoblasts alone and osteoblasts treated with CD61-negative (non-megakaryocytic) cells were used as control cultures. After 48 h in culture, megakaryocytes were removed and osteoblasts immunolocalized for type-1 collagen, osteoprotegerin (OPG), and RANKL expression. Similar cultures were used for RNA extraction with mRNA for Col 1A1, OPG, and RANKL in osteoblasts measured quantitatively by RT-PCR. Osteoblasts cultured alone showed high levels of expression of collagen with 74% (+/-7) of cells staining positively. When cultured with megakaryocytes, the number of positively staining cells remained similar but the intensity of expression was increased 1.54-fold (P < 0.02). OPG was expressed by 32% (+/-6.3) of osteoblasts increasing to 51% (+/-5.5) when cultured in the presence of megakaryocytes (P < 0.01) with a 1.63-fold increase in intensity of expression (P < 0.01). In contrast, osteoblasts cultured with megakaryocytes showed suppression of RANKL expression; 35.6% (+/-5.8) of osteoblasts cultured alone stained positively decreasing to 24.3% (+/-5.3) with a 1.6-fold diminished intensity of expression (P < 0.02). Osteoblasts co-cultured with CD61-negative cells showed no differences in collagen, OPG, or RANKL expression levels compared to osteoblasts cultured alone. mRNA data supported these findings with a 3.1-fold increase in Col 1A1 expression in megakaryocyte-treated cultures compared to controls (P < 0.02). Low-level OPG mRNA expression increased 8.14-fold in osteoblasts cultured in the presence of megakaryocytes (P < 0.01), while RANKL expression was suppressed 3.3-fold (P < 0.02). These results demonstrate that in vitro, megakaryocytes have direct effects on osteoblastic production of factors affecting both bone formation and resorption. These data provide further evidence that megakaryocytes may play an important role in bone remodeling.

Citing Articles

Association between inflammation-related indicators and vertebral fracture in older adults in the United States: A cross-sectional study based on National Health and Nutrition Examination Survey 2013-2014.

Gou Y, Xie X, Yin H, Wu Y, Wen Y, Zhang Y Immun Inflamm Dis. 2024; 12(11):e70047.

PMID: 39508685 PMC: 11542303. DOI: 10.1002/iid3.70047.


Sex-specific association between platelet content and bone mineral density in adults: a cross-sectional study.

Zhang Y, Zhao B, Huang Z, Xie J, Zhou X, Fan C BMC Musculoskelet Disord. 2024; 25(1):875.

PMID: 39487471 PMC: 11529332. DOI: 10.1186/s12891-024-07963-4.


Osteoimmunology of Fracture Healing.

Molitoris K, Huang M, Baht G Curr Osteoporos Rep. 2024; 22(3):330-339.

PMID: 38616228 PMC: 11186872. DOI: 10.1007/s11914-024-00869-z.


Megakaryocyte Secreted Factors Regulate Bone Marrow Niche Cells During Skeletal Homeostasis, Aging, and Disease.

Karnik S, Nazzal M, Kacena M, Bruzzaniti A Calcif Tissue Int. 2023; 113(1):83-95.

PMID: 37243755 PMC: 11179715. DOI: 10.1007/s00223-023-01095-y.


Association between inflammatory markers and bone mineral density: a cross-sectional study from NHANES 2007-2010.

Chen S, Sun X, Jin J, Zhou G, Li Z J Orthop Surg Res. 2023; 18(1):305.

PMID: 37069682 PMC: 10108543. DOI: 10.1186/s13018-023-03795-5.